know more, do more

Advancing endocrinology and improving public health

Join an innovative global community focused on improving patient care, shaping effective policy, and ensuring the future of our field. 

the latest
Meetings & Events

Register Now! ENDO 2026 Prices Increase May 6

April 21, 2026

ENDO 2026, taking place June 13-16 in Chicago, IL, US, is set to deliver three days of dynamic, thought-provoking sessions and discussions on the latest in hormone health and science. Experience ENDO’s most comprehensive scientific program to date. Register by Wednesday, May 6, to save with advance rates.

Professional Development

Grant Aims Accelerator Program Now Open

April 03, 2026

The Grant Aims Accelerator Program pairs an early career professional with an experienced mentor to review the mentee’s Specific Aims draft (or international Specific Aims equivalent) for grant proposals. Exclusive to Endocrine Society members, mentors and mentees will be matched by research interests and will meet informally at the ENDO 2026 to discuss how the specific aims draft can be improved. Register for ENDO and sign up by Monday, May 4.

Store

Warehouse Relocation Update: ESAP 2026, Books, and Merchandise Shipping

April 03, 2026

As we transition to a new warehouse, all orders, including Endocrine Self-Assessment Program (ESAP)™ 2026, books, and merchandise, will ship after May 4. ESAP™ 2026 features 120 new case-based questions that reflect real clinical practice and strengthen clinical judgment. The program includes a book, online learning, and a mobile app. Earn up to 40 AMA PRA Category 1 Credits™ and 40 ABIM MOC credits.

Meetings & Events

Checkpoint Inhibitor–Associated Diabetes: Risk Prediction, Clinical Phenotypes, and Emerging Mechanisms

April 21, 2026

Checkpoint inhibitor–associated diabetes (CIADM) is an increasingly recognized immune-related adverse event. Taking place Wednesday, April 29 at 5:00 PM ET, this webinar will review approaches to risk prediction and pre-treatment screening, strategies to distinguish CIADM from other causes of hyperglycemia, and emerging insights into underlying immunologic mechanisms, with a focus on implications for future prevention and patient care.

Advocacy

Advocacy in Action

April 10, 2026

Read the latest Advocacy in Action on our efforts to: urge Senators to support the INSULIN Act; increase funding for NIH; comment on a Scientific Statement on obesity; and share recent policy communications.

We Are Endocrinology

Deena Adimoolam
“I use media to share a message of prevention and recognition of many endocrine diseases, especially diabetes and obesity. As a member of the Endocrine Society, I have also had the opportunity to continue this work with Society members who share in my vision and passion. I work closely with the Endocrine Society’s Hormone Health Network to spread awareness on various endocrine diseases through patient education tools and media.” – Deena Adimoolam, MD
We are an 18,000 member strong global community
A champion for the Society’s guidelines, Chris has been passionate about improving our guideline development methodology as well as about making guideline content more accessible to readers around the world. – Christopher McCartney, MD

Advantages of Membership

Need more info?

Learn more about the advantages of membership

Endocrine Society News

Keto diet may improve beta cell function in people with type 2 diabetes

April 21, 2026

People with type 2 diabetes on a high-fat, low-carbohydrate diet may have a better chance of reversing their diabetes than those on a low-fat diet, according to a small study published in the Journal of the Endocrine Society.

Moving obesity diagnosis beyond BMI may delay treatment

April 02, 2026

Redefining obesity based not only on body mass index (BMI) but on whether excess body fat is causing measurable health problems may complicate diagnosis and delay treatment, according to an Endocrine Society guideline communication published in The Journal of Clinical Endocrinology & Metabolism.

Endocrine Society endorses bipartisan bill to address insulin affordability

March 25, 2026

The Endocrine Society today endorsed the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act, a bipartisan bill to address insulin affordability introduced by Sens. Jeanne Shaheen (D-NH), Susan Collins (R-ME), Raphael Warnock (D-GA), and John Kennedy (R-LA).

View More

Featured Journal Articles

Cabergoline-Induced Gambling Causing Increased Adrenal Crisis Episodes

January 20, 2026

The authors present a 34-year-old woman with acromegaly who underwent transsphenoidal surgery for an invasive pituitary macroadenoma, which was followed by the development of panhypopituitarism.

Exploring GABA and Kisspeptin Roles in Reproductive and Metabolic Regulation

January 20, 2026

This work aims to determine the role of γ-aminobutyric acid B (GABAB) receptors in Kiss1 cells, studying the effect on central and peripheral systems that regulate reproduction and metabolic homeostasis in Kiss1-GABAB1KO female mice during development and adulthood.

Beneficial Effects of Carbohydrate Restriction in Type 2 Diabetes Can Be Traced to Changes in Hepatic Metabolism

January 20, 2026

We test the hypothesis that the ketogenic diet would decrease de novo lipogenesis and liver fat, which would be associated with restored beta-cell function.

View More
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.